Assessment of Awake Surgery With Electrocorticographic Recordings in the Management of Gliomas and Correlation With Imaging Data (ECoG)

Sponsor
Ramsay Générale de Santé (Other)
Overall Status
Terminated
CT.gov ID
NCT05875935
Collaborator
European Clinical Trial Experts Network (Other)
1
1
1
5.4
0.2

Study Details

Study Description

Brief Summary

This study proposes to analyze data from intraoperative ECoG recordings acquired during wakefulness interventions in order to identify the connection networks involved in cognitive functions. This study also proposes to correlate the ECoG data with the imaging data and to analyze the disturbances of the electrophysiological signals induced by the cortical and subcortical brain lesions: this will make it possible to establish a more detailed mapping of the tumor areas and to compare disturbances recorded to those recorded in healthy areas. Thus, this approach should make it possible to improve the quality of excision of glial lesions located in eloquent areas, while reducing the risk of neurological sequelae and thus improve the survival and quality of life of patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: ECoG : electrocorticography
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
1 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Assessment of Awake Surgery With Electrocorticographic Recordings in the Management of Gliomas and Correlation With Imaging Data
Actual Study Start Date :
Dec 17, 2021
Actual Primary Completion Date :
Apr 17, 2022
Actual Study Completion Date :
May 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Subject with a non-recurrent glial lesion requiring surgery in vigilance

Procedure: ECoG : electrocorticography
The skull and the dura are opened under general anesthesia and the two grids of 64 cortical electrodes will be applied to the cortex, one facing the glial lesion, and the other at a distance from the glial lesion in the so-called area. "Healthy" (non-tumor), before the patient wakes up. They consist of 8 recording slides each comprising 8 electrodes of 2 mm in diameter each spaced 0.5 mm (DispoMed®, USA).

Outcome Measures

Primary Outcome Measures

  1. electrocorticographic recordings [12 months]

    Intraoperative ECoG recordings (raw signals) acquired during awake surgery which in clinical practice couples cortical stimulation and simultaneous ECoG recordings with behavioral tests. The regions defined as electrophysiologically "connected" to the stimulated region will be those for which an afterdischarge is recorded (short-duration rhythmic activity following the stimulation) and/or a cortico-cortical evoked potential is obtained after a average of 5 successive stimulations.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Man or woman over 18 years-old

  • Subject with a non-recurrent glial lesion requiring surgery in vigilant condition;

  • Brain lesion located in the functional zone;

  • Major not protected within the meaning of the law;

  • Subject affiliated to a Health Insurance scheme;

  • No medical contraindication to performing an MRI (pacemaker);

  • No medical contraindication to surgery and anesthesia;

  • Karnofski index> 70;

  • Subject having signed an informed consent.

Exclusion Criteria:
  • Minor subject, pregnant or breastfeeding woman;

  • Major subject subject under measure of legal protection, guardianship or deprived of liberty by judicial or administrative decision;

  • Subject hospitalized without consent;

  • Subject treated with antipsychotics (neuroleptic or lithium);

  • Subject who has already been treated for his glial lesion by surgery and / or radiotherapy;

  • Subject refusing to sign an informed consent.

  • Subject wishing to discontinue participation in the study before completion;

  • Subject for which the surgical intervention and / or the ECoG recording could not be carried out after admission to the operating room (whatever the reason).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clairval Private Hospital Marseille Paca France 13009

Sponsors and Collaborators

  • Ramsay Générale de Santé
  • European Clinical Trial Experts Network

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ramsay Générale de Santé
ClinicalTrials.gov Identifier:
NCT05875935
Other Study ID Numbers:
  • 2019-A02005-52
First Posted:
May 25, 2023
Last Update Posted:
May 25, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 25, 2023